Concepedia

Author

Maria P.A. van Berkel

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

M P A van Berkel, Maria P A van Berkel, Maria P. A. van Berkel, Maria P.A. van Berkel

7

Publications

218

Citations

6

H-Index

17

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam
MP

About

Maria P.A. van Berkel is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in cell biology, tumor biology, and ovarian cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

167

2

Cell Biology

4

4

167

3

Cellular Physiology

1

1

23

4

Immunology

1

1

31

5

Obstetrics

1

1

31

Maria P.A. van Berkel

×

5

Publications

206

Citations

5

H-Index

YearCitations

Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells

Monique C.A. Duyndam, Maria P.A. van Berkel, Josephine C. Dorsman,

Biochemical Pharmacology

2007

76

CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells

Dennis Fontijn, Monique C.A. Duyndam, Maria P.A. van Berkel,

British Journal of Cancer

2006

39

Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

Marcel N.A. Bijman, Cristian A. Hermelink, Maria P.A. van Berkel,

Biochemical Pharmacology

2007

37

Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines

Marcel N.A. Bijman, Maria P.A. van Berkel, Mirjam Kok,

Anti-Cancer Drugs

2009

31

Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility

Marcel N.A. Bijman, Maria P.A. van Berkel, Geerten P. van Nieuw Amerongen,

Biochemical Pharmacology

2008

23

Page 1